Cargando…
PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044696/ http://dx.doi.org/10.1186/1546-0096-11-S2-P224 |
_version_ | 1782319193470795776 |
---|---|
author | Kasapcopur, O Tugal-Tutkun, I Barut, K Erener-Ercan, T Gul, A |
author_facet | Kasapcopur, O Tugal-Tutkun, I Barut, K Erener-Ercan, T Gul, A |
author_sort | Kasapcopur, O |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4044696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40446962014-06-19 PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome Kasapcopur, O Tugal-Tutkun, I Barut, K Erener-Ercan, T Gul, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044696/ http://dx.doi.org/10.1186/1546-0096-11-S2-P224 Text en Copyright © 2013 Kasapcopur et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Kasapcopur, O Tugal-Tutkun, I Barut, K Erener-Ercan, T Gul, A PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title | PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title_full | PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title_fullStr | PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title_full_unstemmed | PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title_short | PReS-FINAL-2234: Successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
title_sort | pres-final-2234: successful canakunimab treatment in uveitis secondary to cryopyrin-associated periodic syndrome |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044696/ http://dx.doi.org/10.1186/1546-0096-11-S2-P224 |
work_keys_str_mv | AT kasapcopuro presfinal2234successfulcanakunimabtreatmentinuveitissecondarytocryopyrinassociatedperiodicsyndrome AT tugaltutkuni presfinal2234successfulcanakunimabtreatmentinuveitissecondarytocryopyrinassociatedperiodicsyndrome AT barutk presfinal2234successfulcanakunimabtreatmentinuveitissecondarytocryopyrinassociatedperiodicsyndrome AT erenerercant presfinal2234successfulcanakunimabtreatmentinuveitissecondarytocryopyrinassociatedperiodicsyndrome AT gula presfinal2234successfulcanakunimabtreatmentinuveitissecondarytocryopyrinassociatedperiodicsyndrome |